Tech Company Financing Transactions

RareCyte Funding Round

Agilent Technologies, Arboretum Ventures and F-Prime Capital participated in a $24 million venture round for RareCyte. The round was announced on 9/13/2021.

Transaction Overview

Company Name
RareCyte
Announced On
9/13/2021
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Undisclosed
Investors

Agilent Technologies (Lead Investor)

Arboretum Ventures (Lead Investor)

F-Prime Capital (Lead Investor) (Robert Weisskoff)

Logos Capital (Lead Investor)

5AM Ventures (Andrew Schwab)

HealthQuest Capital (David Kabakoff)

private investors (Ron Seubert)

Proceeds Purpose
The new funding will fuel the commercialization and development of its new Orion cell imaging and analysis platform, launched last year, and enable expansion of its other products into global markets.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2601 4th Ave.
Seattle, WA 98121
USA
Phone
(206) 455-9092
Website
www.rarecyte.com
Email Address
[email protected]
Overview
RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. Our team of biologists and engineers is dedicated to building innovative technologies to better understand human health and disease.
Profile
RareCyte LinkedIn Company Profile
Social Media
RareCyte Company Twitter Account
Company News
RareCyte News
Facebook
RareCyte on Facebook
YouTube
RareCyte on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Joe Victor
  Joe Victor LinkedIn Profile  Joe Victor Twitter Account  Joe Victor News  Joe Victor on Facebook
Chief Medical Officer
Eric Kaldjian
  Eric Kaldjian LinkedIn Profile  Eric Kaldjian Twitter Account  Eric Kaldjian News  Eric Kaldjian on Facebook
VP - Bus. Development
Leighton Howells
  Leighton Howells LinkedIn Profile  Leighton Howells Twitter Account  Leighton Howells News  Leighton Howells on Facebook
VP - Engineering
Steve Reese
  Steve Reese LinkedIn Profile  Steve Reese Twitter Account  Steve Reese News  Steve Reese on Facebook
VP - Finance
James Cooper
  James Cooper LinkedIn Profile  James Cooper Twitter Account  James Cooper News  James Cooper on Facebook
VP - Operations
Tony Dedeo
  Tony Dedeo LinkedIn Profile  Tony Dedeo Twitter Account  Tony Dedeo News  Tony Dedeo on Facebook
VP - Product Management
Josh Nordberg
  Josh Nordberg LinkedIn Profile  Josh Nordberg Twitter Account  Josh Nordberg News  Josh Nordberg on Facebook
VP - R & D
Tad George
  Tad George LinkedIn Profile  Tad George Twitter Account  Tad George News  Tad George on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/13/2021: GenXComm venture capital transaction
Next: 9/13/2021: Evolon venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.